Question 1
Question
Drug: “Substances that produce a change in cellular or physiological functioning of humans.”
Question 2
Question
For Drugs... End-point of the supply chain drives demand
Question 3
Question
The five factors influencing prescribing behavior are:
Answer
-
Education
-
Colleagues or other health care providers
-
Control and regulatory mechanisms
-
Demands by consumers and society
-
Promotional activities by drug manufacturers
-
Kickbacks from pharmaceutical companies
Question 4
Question
What are the two main acts used by the FDA to control pharmaceuticals?
Answer
-
Food, Drug, and Cosmetic Act
-
Public Health Service Act
-
HIPPA Act
-
Omnibus Act
Question 5
Question
Non-FDA-approved (“off-label”) indications are uses of a product that were not approved by the FDA, but have shown value after approval based on postmarketing research.
Question 6
Question
Non-FDA-approved indications can be promoted by the manufacturer.
Question 7
Question
The FDA started allowing direct advertising in what year?
Question 8
Question
Drug prices: Suggested price determined by manufacturer is usually a different price (much lower) that is actually paid out-of-pocket by most consumers based on their insurance plan.
Question 9
Question
This phase in the drug development is tested on non-human subject
Answer
-
Phase 0
-
Phase 1
-
Phase 2
-
Phase 3
-
Phase 4
Question 10
Question
Which of the phases allow human trail?
Answer
-
Phase 0
-
Phase 1
-
Phase 2
-
Phase 3
Question 11
Question
Phase 1 trials allow 20-80 people (for safety, dosing range, and side effects). Phase 2 trials allow 100-300 people (for effective and further evaluation of safety). Phase 3 trials allow how many people (to confirm effectiveness, monitor side effects, and compared it to commonly used treatments)?
Answer
-
500-1000
-
1000-3000
-
4000-5000
Question 12
Question
Phase 4 trial - post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.